PROFILPELAJAR.COM

Bachem Holding AG
	Offices in Bubendorf, Switzerland
Company type	Stock company
Traded as	SIX: BANB
ISIN	CH0012530207
Industry	Chemicals, biotechnology, pharmaceuticals
Founded	1971
Headquarters	Bubendorf, Switzerland
Revenue	CHF 261.6 million (2017)
Number of employees	1057
Website	bachem.com

Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active pharmaceutical ingredients, in the production of peptide-based biochemicals and in the development of manufacturing processes for these compounds.^{[citation needed]} It was founded in 1971 and is a subsidiary of Ingro Finanz AG.^[1] The head office is in Bubendorf in the canton of Basel-Landschaft; there are production sites in Vionnaz in the canton of Valais, in the Californian cities of Vista and Torrance, and in Great Britain in St Helens near Liverpool, with a sales and distribution site in Tokyo.^{[citation needed]} At the end of 2017, it had 1057 employees, revenue of CHF 261.6 million, and net income of CHF 41.8 million.^[1]

History

In 2013 the company entered an agreement with GlyTech Inc. to cooperate on the production of glycosylated proteins and peptides.^[2]^{[promotional source?]}

In 2015 it bought American Peptide, a bio-technology company in Sunnyvale, California.^[3]